Cutera, Inc. (NASDAQ:CUTR) stock price target bumped up to $16.00, released a research note earlier today by Zacks Investment Research
- Updated: October 17, 2016
Just yesterday Cutera, Inc. (NASDAQ:CUTR) traded 0.77% higher at $14.35. Cutera, Inc.’s 50-day moving average is $11.91 and its 200-day moving average is $11.21. The last closing price is up 27.98% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 20,284 shares of the stock were exchanged, down from an average trading volume of 43,378
Reporting a potential upside of 0.11%, Zacks Investment Research raised the target price of Cutera, Inc. (NASDAQ:CUTR) to $16.00
See Chart Below
Cutera, Inc. has a 52 week low of $9.83 and a 52 week high of $15.10 The company’s market cap is currently $0.
General Company Details For Cutera, Inc. (NASDAQ:CUTR)
Cutera, Inc. is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers. Each of its laser and other energy-based platforms consists of one or more hand pieces and a console that incorporates a universal graphical user interface, a laser or other energy-based module, control system software and high voltage electronics. enlighten is a dual wavelength (1,064 nanometer + 532 nanometer) and dual pulse duration (750 picosecond (ps) and 2 nanosecond (ns)) laser system. excel V is a vascular and benign pigmented lesion treatment platform designed for the core-market of dermatologists and plastic surgeons.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.